Department of Internal Medicine, Digestive Disease Centre, Konkuk University School of Medicine, Seoul, South Korea.
HPB (Oxford). 2012 Mar;14(3):185-93. doi: 10.1111/j.1477-2574.2011.00424.x. Epub 2012 Jan 6.
This study aimed to determine longterm outcomes and factors associated with increased survival after photodynamic therapy (PDT) compared with endoscopic biliary drainage alone in patients presenting with advanced hilar cholangiocarcinoma (CC).
A retrospective analysis of the institutional database identifying all patients who presented with a diagnosis of hilar CC between December 1999 and January 2011 was conducted.
Of the 232 patients identified, 72 (31%) were treated with PDT (Group A) and 71 (31%) were treated with endoscopic biliary drainage alone (Group B). Median survival was 9.8 months [95% confidence interval (CI) 7.42-12.25] in Group A and 7.3 months (95% CI 4.79-9.88) in Group B (P= 0.029). On multivariate analysis, biliary drainage without PDT (P= 0.025) and higher T-stage (P= 0.002) were significant predictors of shorter survival in all patients. In a subgroup analysis of patients in the PDT group, lower pre-PDT bilirubin level (P= 0.005), multiple PDT treatments (P= 0.044) and shortened time to treatment after diagnosis (P= 0.013) were significant predictors of improved survival. Median metal stent patency was longer in Group A than in Group B (215 days vs. 181 days; P= 0.018).
Photodynamic therapy with stenting resulted in longer survival than stenting alone. Early PDT after diagnosis and multiple PDT treatments were shown to have survival benefits. Metal stent patency was longer in patients receiving PDT. Higher T-stage appears to be a predictor of early mortality in advanced bile duct cancer treated with PDT.
本研究旨在比较 PDT 与单纯内镜胆道引流治疗晚期肝门部胆管癌(CC)患者的长期疗效及生存率的影响因素。
回顾性分析了 1999 年 12 月至 2011 年 1 月期间确诊为肝门部 CC 的所有患者的机构数据库。
在 232 例患者中,72 例(31%)接受 PDT(A 组)治疗,71 例(31%)接受单纯内镜胆道引流治疗(B 组)。A 组中位生存时间为 9.8 个月(95%CI:7.42-12.25),B 组为 7.3 个月(95%CI:4.79-9.88)(P=0.029)。多因素分析显示,未行 PDT 的胆道引流(P=0.025)和更高的 T 分期(P=0.002)是所有患者生存时间较短的显著预测因素。在 PDT 组患者的亚组分析中,较低的 PDT 前胆红素水平(P=0.005)、多次 PDT 治疗(P=0.044)和诊断后治疗时间缩短(P=0.013)是生存时间改善的显著预测因素。A 组金属支架通畅时间长于 B 组(215 天 vs. 181 天;P=0.018)。
支架置入联合 PDT 治疗比单纯支架置入的生存时间更长。早期诊断后进行 PDT 治疗和多次 PDT 治疗具有生存获益。接受 PDT 治疗的患者金属支架通畅时间更长。T 分期较高似乎是 PDT 治疗晚期胆管癌早期死亡的预测因素。